Back to video list Back to Home The Evolution of Pharmacological Treatments and Treatment Goals in MDD and Anxiety You may also like Schizophrenia Article Improving cognition and motivation in schizophrenia to address patient’s goal of restoring social functioning Bipolar Schizophrenia Article Dopamine synthesis is the common factor in genetic and environmental risks in schizophrenia Schizophrenia Bipolar Article Can neuroimaging lead to the development of biomarkers in schizophrenia? Mental Health Article Parity of care in mental health: scale of the challenge